Drug Shortage Report for OZURDEX
| Report ID | 80819 |
| Drug Identification Number | 02363445 |
| Brand name | OZURDEX |
| Common or Proper name | dexamethasone intravitreal implant |
| Company Name | ABBVIE CORPORATION |
| Market Status | MARKETED |
| Active Ingredient(s) | DEXAMETHASONE |
| Strength(s) | 0.7MG |
| Dosage form(s) | IMPLANT |
| Route of administration | INTRAVITREAL |
| Packaging size | 1 implant |
| ATC code | S01BA |
| ATC description | ANTIINFLAMMATORY AGENTS |
| Reason for shortage | Disruption of the manufacture of the drug. |
| Anticipated start date | 2019-04-15 |
| Actual start date | |
| Estimated end date | 2019-04-30 |
| Actual end date | 2019-04-26 |
| Shortage status | Resolved |
| Updated date | 2019-04-27 |
| Company comments | Rebuilding in country inventory levels following prior supply disruption. Resupply in late April will be sufficient quantity to meet ongoing customer & patient demand. |
| Health Canada comments | |
| Tier 3 Status | No |
| Contact Address | 8401 TRANS-CANADA HIGHWAY SAINT-LAURENT, QUEBEC CANADA H4S 1Z1 |
| Company contact information | Should you require any additional information, please contact our Customer Service Department at 1-888-704-8270. |
Version History
Click on "Compare" below to view the full report history and compare to other versions.
| Version Number | Date Updated | Language | |
|---|---|---|---|
| v7 | 2019-04-27 | English | Compare |
| v6 | 2019-04-26 | French | Compare |
| v5 | 2019-04-26 | English | Compare |
| v4 | 2019-04-16 | English | Compare |
| v3 | 2019-04-08 | French | Compare |
| v2 | 2019-04-08 | English | Compare |
| v1 | 2019-04-08 | English | Compare |
Showing 1 to 7 of 7